loadpatents
name:-0.052144050598145
name:-0.043797969818115
name:-0.0014657974243164
Ritter; Kurt Patent Filings

Ritter; Kurt

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ritter; Kurt.The latest application filed is for "azetidine compounds as grp119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders".

Company Profile
1.50.52
  • Ritter; Kurt - Frankfurt am Main DE
  • Ritter; Kurt - Frankfurt N/A DE
  • Ritter; Kurt - Heidelberg N/A DE
  • Ritter; Kurt - Scottsdale AZ
  • Ritter; Kurt - Newton MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Azetidine compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
Grant 10,392,366 - Schwink , et al. A
2019-08-27
Azetidine Compounds As Grp119 Modulators For The Treatment Of Diabetes, Obesity, Dyslipidemia And Related Disorders
App 20180237419 - Schwink; Lothar ;   et al.
2018-08-23
Isoindolinone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
Grant 9,908,868 - Schwink , et al. March 6, 2
2018-03-06
Substituted indanone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
Grant 9,896,434 - Schwink , et al. February 20, 2
2018-02-20
Substituted fused heterocycles as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
Grant 9,758,520 - Schwink , et al. September 12, 2
2017-09-12
Substituted Indanone Compounds As Gpr119 Modulators For The Treatment Of Diabetes, Obesity, Dyslipidemia And Related Disorders
App 20170029405 - SCHWINK; Lothar ;   et al.
2017-02-02
Substituted Fused Heterocycles As Gpr119 Modulators For The Treatment Of Diabetes, Obesity, Dyslipidemia And Related Disorders
App 20170022198 - SCHWINK; Lothar ;   et al.
2017-01-26
Isoindolinone Compounds As Gpr119 Modulators For The Treatment Of Diabetes, Obesity, Dyslipidemia And Related Disorders
App 20170022182 - SCHWINK; Lothar ;   et al.
2017-01-26
Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
Grant 8,901,114 - Boehme , et al. December 2, 2
2014-12-02
Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
Grant 8,895,547 - Boehme , et al. November 25, 2
2014-11-25
Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
Grant 8,871,758 - Boehme , et al. October 28, 2
2014-10-28
Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
Grant 8,846,666 - Boehme , et al. September 30, 2
2014-09-30
Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
Grant 8,828,994 - Boehme , et al. September 9, 2
2014-09-09
Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
Grant 8,828,995 - Boehme , et al. September 9, 2
2014-09-09
Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
Grant 8,809,324 - Boehme , et al. August 19, 2
2014-08-19
Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
Grant 8,809,325 - Boehme , et al. August 19, 2
2014-08-19
Isoquinoline derivatives
Grant 8,722,671 - Plettenburg , et al. May 13, 2
2014-05-13
Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
Grant 8,710,050 - Boehme , et al. April 29, 2
2014-04-29
Oxathiazine Derivatives Which Are Substituted With Benzyl Or Heteromethylene Groups, Method For Producing Them, Their Use As Medicine And Drug Containing Said Derivatives And The Use Thereof
App 20140066437 - Boehme; Thomas ;   et al.
2014-03-06
Tetrasubstituted Oxathiazine Derivatives, Method For Producing Them, Their Use As Medicine And Drug Containing Said Derivatives And The Use Thereof
App 20140024584 - Boehme; Thomas ;   et al.
2014-01-23
Di- And Tri-substituted Oxathiazine Derivatives, Method For The Production Thereof, Use Thereof As Medicine And Drug Containing Said Derivatives And Use Thereof
App 20130345125 - Boehme; Thomas ;   et al.
2013-12-26
Branched Oxathiazine Derivatives, Method For The Production Thereof, Use Thereof As Medicine And Drug Containing Said Derivatives And Use Thereof
App 20130345126 - Boehme; Thomas ;   et al.
2013-12-26
Oxathiazine Derivatives Substituted With Carbocycles Or Heterocycles, Method For Producing Same, Drugs Containing Said Compounds, And Use Thereof
App 20130345128 - Boehme; Thomas ;   et al.
2013-12-26
Novel Substituted Phenyl-oxathiazine Derivatives, Method For Producing Them, Drugs Containing Said Compounds And The Use Thereof
App 20130345127 - Boehme; Thomas ;   et al.
2013-12-26
Benzyl-oxathiazine Derivatives Substituted With Adamantane And Noradamantane, Medicaments Containing Said Compounds And Use Thereof
App 20130345207 - Boehme; Thomas ;   et al.
2013-12-26
Di And Tri - Substituted Oxathiazine Derivatives, Method For The Production, Method For The Production Thereof, Use Thereof As Medicine And Drug Containing Said Derivatives And Use Thereof
App 20130338150 - Boehme; Thomas ;   et al.
2013-12-19
Novel Substituted Phenyl-oxathiazine Derivatives, Method For Producing Them, Drugs Containing Said Compounds And The Use Thereof
App 20130338066 - Boehme; Thomas ;   et al.
2013-12-19
Isoquinoline derivatives
Grant 8,501,736 - Plettenburg , et al. August 6, 2
2013-08-06
Antineoplastic peptides
Grant 8,440,626 - Amberg , et al. May 14, 2
2013-05-14
Cyclohexylamin Isoquinolone Derivatives
App 20110251226 - Plettenburg; Oliver ;   et al.
2011-10-13
Isoquinoline Derivatives
App 20110245248 - Plettenburg; Oliver ;   et al.
2011-10-06
Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
Grant 7,935,819 - Halley , et al. May 3, 2
2011-05-03
Antineoplastic Peptides
App 20110098235 - AMBERG; Wilhelm ;   et al.
2011-04-28
Pyrazolopyridine derivatives as inhibitors of .beta.-Adrenergic receptor kinase 1
Grant 7,910,602 - Steinhagen , et al. March 22, 2
2011-03-22
Cyclic urea compounds, preparation thereof and pharmaceutical use thereof as kinase inhibitors
Grant 7,825,115 - Patek , et al. November 2, 2
2010-11-02
Antineoplastic peptides
Grant 7,807,779 - Amberg , et al. October 5, 2
2010-10-05
Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
Grant 7,759,379 - Strobel , et al. July 20, 2
2010-07-20
Benzimidazole-derivatives as factor Xa inhibitors
Grant 7,741,341 - Nazare , et al. June 22, 2
2010-06-22
Isoquinoline Derivatives
App 20090088429 - PLETTENBURG; Oliver ;   et al.
2009-04-02
Novel Sulphur-Containing Cyclic Urea Derivatives, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors
App 20090082329 - HALLEY; Frank ;   et al.
2009-03-26
Novel Cyclic Urea Derivatives, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors
App 20090082379 - HALLEY; Frank ;   et al.
2009-03-26
New Indole Derivatives As Factor Xa Inhibitors
App 20090069565 - NAZARE; Mark ;   et al.
2009-03-12
Azaindole-Derivatives As Factor Xa Inhibitors
App 20080280946 - NAZARE; Marc ;   et al.
2008-11-13
Antineoplastic peptides
App 20080234205 - Amberg; Wilhelm ;   et al.
2008-09-25
Pyrazolopyridine derivatives as inhibitors of beta-Adrenergic Receptor Kinase 1
App 20080227777 - STEINHAGEN; Henning ;   et al.
2008-09-18
Method of identifying inhibitors of Lck
Grant 7,400,979 - Borhani , et al. July 15, 2
2008-07-15
Cyclic Urea Compounds, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors
App 20080108654 - PATEK; Marcel ;   et al.
2008-05-08
Antineoplastic peptides
Grant 7,368,528 - Amberg , et al. May 6, 2
2008-05-06
Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
Grant 7,354,933 - Patek , et al. April 8, 2
2008-04-08
Pyrazolopyrimidines as therapeutic agents
Grant 7,332,497 - Hirst , et al. February 19, 2
2008-02-19
Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors
App 20080021029 - Strobel; Hartmut ;   et al.
2008-01-24
Azaindole-derivatives as factor Xa inhibitors
Grant 7,317,027 - Nazare , et al. January 8, 2
2008-01-08
Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors
App 20080004300 - Strobel; Hartmut ;   et al.
2008-01-03
Heterocycle-Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors
App 20070259891 - Strobel; Hartmut ;   et al.
2007-11-08
Indole derivatives as factor Xa inhibitors
Grant 7,196,103 - Nazare , et al. March 27, 2
2007-03-27
Facial support device
App 20070037120 - Ritter; Kurt
2007-02-15
Kinase inhibitors as therapeutic agents
Grant 7,071,199 - Hirst , et al. July 4, 2
2006-07-04
Antineoplastic peptides
App 20060009392 - Amberg; Wilhelm ;   et al.
2006-01-12
Pyrazolopyrimidines as therapeutic agents
Grant 6,921,763 - Hirst , et al. July 26, 2
2005-07-26
Indole derivatives as factor Xa inhibitors
Grant 6,906,084 - Nazare , et al. June 14, 2
2005-06-14
New indole derivatives as factor Xa inhibitors
App 20050043302 - Nazare, Marc ;   et al.
2005-02-24
Indole derivatives as factor Xa inhibitors
App 20050033049 - Nazare, Marc ;   et al.
2005-02-10
Azaindole-derivatives as factor Xa inhibitors
App 20050009828 - Nazare, Marc ;   et al.
2005-01-13
Benzimidazole-derivatives as factor Xa inhibitors
App 20050009829 - Nazare, Marc ;   et al.
2005-01-13
Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
App 20040248884 - Patek, Marcel ;   et al.
2004-12-09
Pyrazolopyrimidines as therapeutic agents
App 20040006083 - Hirst, Gavin C. ;   et al.
2004-01-08
Pyrazolopyrimidines as therapeutic agents
Grant 6,660,744 - Hirst , et al. December 9, 2
2003-12-09
New indole derivatives as factor Xa inhibitors
App 20030199689 - Nazare, Marc ;   et al.
2003-10-23
Method of identifying inhibitors of Lck
App 20030175935 - Borhani, David W. ;   et al.
2003-09-18
Transition metal mediated process
App 20030109714 - Wishart, Neil ;   et al.
2003-06-12
Transition metal mediated process
App 20030009034 - Wishart, Neil ;   et al.
2003-01-09
Method of identifying inhibitors of CDC25
App 20020183249 - Taylor, Neil R. ;   et al.
2002-12-05
Pyrazolopyrimidines as therapeutic agents
App 20020156081 - Hirst, Gavin C. ;   et al.
2002-10-24
Dolastatin 15 derivatives
App 20010018422 - Ritter, Kurt ;   et al.
2001-08-30
Antineoplastic peptides
App 20010009901 - Amberg, Wilhelm ;   et al.
2001-07-26
Compounds useful for the synthesis of dolastatin analogs
Grant 6,248,865 - Amberg , et al. June 19, 2
2001-06-19
Dolastatin 15 derivatives
Grant 5,985,837 - Ritter , et al. November 16, 1
1999-11-16
Preparation of active peptides
Grant 5,965,700 - Amberg , et al. October 12, 1
1999-10-12
Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
Grant 5,965,537 - Ritter , et al. October 12, 1
1999-10-12
Oligopeptides, the preparation and use thereof
Grant 5,807,984 - Kling , et al. September 15, 1
1998-09-15
Peptides, the preparation and use thereof
Grant 5,502,032 - Haupt , et al. March 26, 1
1996-03-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed